Breast Cancer News
In this section, access cutting-edge news about breast cancer in young women including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
NEW YORK (Reuters Health) - Women under 40 who use estrogen to ease menopause symptoms after having their ovaries removed do not have an increased risk of breast cancer, according to a new study.
Use of an ovarian suppression medicine during chemotherapy to protect ovaries of premenopausal women shows no difference for menstruation after treatment.
NEW YORK (Reuters Health) - Cancer treatment can sometimes lead to infertility, but young women are less likely than young men to be informed of that risk, a new study suggests.
Children born to mothers who had chemotherapy during pregnancy show long-term normal development.
Younger women who want to become pregnant after treatment but are unable to conceive experience long-term emotional distress related to that infertility.
In this analysis of studies over 40 years, an international research team found that pregnancy is safe for women with a history of breast cancer and does not hurt overall survival. The study, published in the European Journal of Cancer, also looked at related issues, including why some research has shown a possibly protective effect of pregnancy.
Young women diagnosed with breast cancer are more likely than healthy or older women with breast cancer to have difficulties with quality of life, fertility and menopausal concerns, and behavioral health, according to a systematic review.
NEW YORK (Reuters Health) - Young women with cancer often aren't counseled about the risk of losing their fertility due to treatment or their options for saving their eggs, a new study from California suggests.
In a five-year review of 20 clinical trials, tamoxifen was shown to safely reduce both 15-year risk for recurrence and death in early-stage estrogen receptor-positive breast cancer.
NEW YORK (Reuters) - The Novartis osteoporosis drug Zometa failed to improve disease free survival of early breast cancer patients in a large clinical trial, but some benefit was observed in older patients who took the medicine, researchers said.